Faron Pharmaceuticals Oy (LON:FARN) Stock Passes Above 50 Day Moving Average – What’s Next?

Faron Pharmaceuticals Oy (LON:FARN)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 42.59 and traded as high as GBX 44. Faron Pharmaceuticals Oy shares last traded at GBX 41.50, with a volume of 468,191 shares traded.

Faron Pharmaceuticals Oy Price Performance

The firm has a market capitalization of £85.82 million, a PE ratio of -1.92 and a beta of 1.12. The business has a 50-day moving average of GBX 42.58 and a 200 day moving average of GBX 63.78. The company has a current ratio of 0.84, a quick ratio of 1.09 and a debt-to-equity ratio of -133.35.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.